The U.S. Food and Drug Administration has appointed George Francis Tidmarsh, M.D., Ph.D., as director of the Center for Drug Evaluation and Research (CDER).
The CDER ensures the protection and effectiveness of over-the-counter and pharmaceuticals, together with biologics and generics, to guard public well being within the United States. Its regulatory function additionally extends to on a regular basis merchandise equivalent to fluoride toothpaste and sunscreens.
Tidmarsh is a medical physician and holds a Ph.D. in cancer biology from Stanford University, where he additionally accomplished a residency in pediatrics and subspecialty coaching in pediatric oncology and neonatology. He brings to the function of director greater than 30 years of expertise in biotechnology, medical medication, and regulatory science.
“Dr. Tidmarsh is an achieved physician-scientist and chief whose expertise spans the total arc of drug growth — from bench to bedside,” FDA Commissioner Marty Makary, M.D., M.P.H., mentioned in an announcement. “His appointment to guide CDER brings distinctive scientific, regulatory, and operational experience to the company. I look ahead to working with him to strengthen our drug evaluation applications, foster innovation, and advance cross-agency initiatives that enhance well being outcomes for the American public.”
Tidmarsh cofounded Stanford’s Master of Translational Research and Applied Medicine program, which trains college students and researchers to show scientific discoveries into medical options. He has additionally led the event of seven FDA-approved medication and headed up a number of biopharmaceutical firms. He has been concerned in advancing therapies that handle severe unmet medical wants, in line with the FDA.
More data:
More Information
Citation:
FDA picks George Tidmarsh to go Center for Drug Evaluation and Research ( 23)
24
fda-george-tidmarsh-center-drug.html
The content material is offered for data functions solely.